Literature DB >> 29493455

Effects of Estrogen in Gender-dependent Fetal Programming of Adult Cardiovascular Dysfunction.

Zewen Chen1,2, Lei Wang1, Jun Ke1,2, Daliao Xiao1.   

Abstract

BACKGROUND: Epidemiological studies and experimental studies have demonstrated that intrauterine adverse environment increases the risk of Cardiovascular Disease (CVD) in adulthood. However, whether an individual develops a cardiovascular dysfunctional phenotype may depend on genetic background, age, and sex.
METHODS: In this review, we summarize some of the recent experimental animal studies in the developmental programming of adult CVD with an emphasis on sex differences and the potential role of estrogen in mediating sexual dimorphism.
RESULTS: Few epidemiological studies report the effect of sex on the developmental programming of CVD. However, numerous experimental animal studies have shown a sex difference in fetal programming of adult cardiovascular dysfunction. Most of the animal studies indicate that male offspring develop cardiovascular dysfunction and CVD in adulthood, whereas adult females appear to be protected. Estrogen is one of the key factors that contributes to the sex difference of adult CVD. Estrogen/its Receptor (ER) may interact with the RAS system by changes of DNA methylation patterns at the target gene promoter, serve as an antioxidant to counteract the prenatal insults-induced heightened ROS, and function as an eNOS activator to increase vasodilation, resulting in the protection of female offspring from the development of hypertension and other CVDs.
CONCLUSION: These studies suggest that estrogen/ER may contribute to sex differences in cardiovascular response to an adverse intrauterine environment and play a significant role in modulating the cardiovascular response in adulthood. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Sex difference; blood pressure; cardiovascular dysfunction; estrogen; fetal programming; hypertensive.

Mesh:

Substances:

Year:  2019        PMID: 29493455      PMCID: PMC6193848          DOI: 10.2174/1570161116666180301142453

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  46 in total

Review 1.  In utero programming of cardiovascular disease.

Authors:  D J Barker
Journal:  Theriogenology       Date:  2000-01-15       Impact factor: 2.740

Review 2.  [Vascular health of the ageing woman].

Authors:  Petri Haapalahti; Tomi Mikkola
Journal:  Duodecim       Date:  2015

Review 3.  Estrogen-based hormone therapy in women with primary ovarian insufficiency: a systematic review.

Authors:  Nydia Burgos; Dahima Cintron; Paula Latortue-Albino; Valentina Serrano; Rene Rodriguez Gutierrez; Stephanie Faubion; Gabriela Spencer-Bonilla; Patricia J Erwin; Mohammad Hassan Murad
Journal:  Endocrine       Date:  2017-10-16       Impact factor: 3.633

4.  17 beta-estradiol regulation of human endothelial cell basal nitric oxide release, independent of cytosolic Ca2+ mobilization.

Authors:  T Caulin-Glaser; G García-Cardeña; P Sarrel; W C Sessa; J R Bender
Journal:  Circ Res       Date:  1997-11       Impact factor: 17.367

5.  Prenatal exposure to nicotine modifies kidney weight and blood pressure in genetically susceptible rats: a case of gene-environment interaction.

Authors:  Zdenka Pausová; Tomás Paus; Lucie Sedová; Julie Bérubé
Journal:  Kidney Int       Date:  2003-09       Impact factor: 10.612

6.  Infant mortality, childhood nutrition, and ischaemic heart disease in England and Wales.

Authors:  D J Barker; C Osmond
Journal:  Lancet       Date:  1986-05-10       Impact factor: 79.321

7.  Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).

Authors:  Christina Magnussen; Teemu J Niiranen; Francisco M Ojeda; Francesco Gianfagna; Stefan Blankenberg; Inger Njølstad; Erkki Vartiainen; Susana Sans; Gerard Pasterkamp; Maria Hughes; Simona Costanzo; Maria Benedetta Donati; Pekka Jousilahti; Allan Linneberg; Tarja Palosaari; Giovanni de Gaetano; Martin Bobak; Hester M den Ruijter; Ellisiv Mathiesen; Torben Jørgensen; Stefan Söderberg; Kari Kuulasmaa; Tanja Zeller; Licia Iacoviello; Veikko Salomaa; Renate B Schnabel
Journal:  Circulation       Date:  2017-10-16       Impact factor: 29.690

8.  Perinatal nicotine exposure increases angiotensin II receptor-mediated vascular contractility in adult offspring.

Authors:  DaLiao Xiao; Chiranjib Dasgupta; Yong Li; Xiaohui Huang; Lubo Zhang
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 9.  The protective role of estrogen and estrogen receptors in cardiovascular disease and the controversial use of estrogen therapy.

Authors:  Andrea Iorga; Christine M Cunningham; Shayan Moazeni; Gregoire Ruffenach; Soban Umar; Mansoureh Eghbali
Journal:  Biol Sex Differ       Date:  2017-10-24       Impact factor: 5.027

10.  Pregnancy Augments G Protein Estrogen Receptor (GPER) Induced Vasodilation in Rat Uterine Arteries via the Nitric Oxide - cGMP Signaling Pathway.

Authors:  Teresa Tropea; Ernestina Marianna De Francesco; Damiano Rigiracciolo; Marcello Maggiolini; Mark Wareing; George Osol; Maurizio Mandalà
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

View more
  1 in total

1.  Oxidative Stress Mediates the Fetal Programming of Hypertension by Glucocorticoids.

Authors:  Jeremy Lamothe; Sandhya Khurana; Sujeenthar Tharmalingam; Chad Williamson; Collin J Byrne; Simon J Lees; Neelam Khaper; Aseem Kumar; T C Tai
Journal:  Antioxidants (Basel)       Date:  2021-03-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.